Gene therapy approaches targeting other types of IRDs, especially RDH12 (retinol dehydrogenase 12)-associated retinal diseases, for which there is no available treatment, are being developed and already demonstrating promising results [6,7]. The gene discussed is RDH12; the disease is respiratory distress syndrome in premature infants.